Home > Insider Trading > Filing (0001225208-10-021288)

Filing Details

Accession Number:: 0001225208-10-021288
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-09-22 16:29:41
Reporting Period:: 2010-09-20

Filing Date:: 2010-09-22
Accepted Time:: 2010-09-22 16:29:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885725	Boston Scientific Corp	BSX	Surgical & Medical Instruments & Apparatus (3841)	042695240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
901458	M Peter Nicholas	One Boston Scientific Place Natick MA 01760-1537		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-09-20	25,000	$5.47	6,181,021	No	4	S	Indirect	By Ltd. Partnership
Common Stock	Disposition	2010-09-20	125,000	$0.00	6,056,021	No	4	J	Indirect	By Ltd. Partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Ltd. Partnership
No	4	J	Indirect	By Ltd. Partnership

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Forward Sale Contract (obligation to sell)	Disposition	2010-09-20	125,000	$0.00	125,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2011-09-19	2011-09-19	No	4	J	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	9,212,125	Direct
Common Stock	2,413,088	Indirect	By Trust 2

Footnotes

Sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
Weighted average sales price reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $5.55 to $5.40. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
On August 26, 2009, a family limited partnership of which the reporting person is a general and limited partner, Promerica LP, entered into a Rule 10b5-1 trading plan with an unaffiliated bank to execute a series of variable prepaid forward sale contracts. On September 20, 2010, Promerica settled a prepaid variable contract originally entered into on September 18, 2009. At the initiation of the contract, the bank paid $1,100,294.10 to the reporting person.
Under the contract reported on this form, Promerica was obligated to deliver to the bank up to 125,000 shares of the Issuer?s common stock depending on the market price at maturity on September 19, 2011. In addition, if the market price per share was equal to or greater than $13.137 on the first anniversary of the contract date, the bank would be obligated to pay an additional amount, determined by the bank based on the stock price at the time, to Promerica three business days after the first anniversary. If the market price per share on the first anniversary of the contract date was less than $13.137 the contract would then be terminated and Promerica would deliver shares to the bank pursuant to the early termination provision in the contract.
Upon early termination, if the market price per share was equal to or less than $10.9482 Promerica would deliver 125,000 shares to the bank and if the market price per share was greater than $10.9482, Promerica would deliver a fewer number of shares. The closing market price per share on September 20, 2010 was $5.54. Accordingly, Promerica transferred to the bank 125,000 shares of the Issuer?s common stock.
Shares held by a trust of which the reporting persons spouse and brother are trustees and the reporting person's spouse and children are beneficiaries.